Neil M. Barth
Keine laufenden Positionen mehr
Profil
Neil M.
Barth served as Executive Medical Director at Hoag Memorial Hospital Presbyterian, Inc. and as President & Medical Director at Newport Pacific Medical Associates.
He also held the position of Chief Medical Officer at Veracyte, Inc., Agendia NV, Ambry Genetics Corp., and Agendia, Inc. Barth earned a doctorate degree from the University of Toledo Medical Center.
Ehemalige bekannte Positionen von Neil M. Barth
Unternehmen | Position | Ende |
---|---|---|
Newport Pacific Medical Associates | Präsident | - |
Ambry Genetics Corp.
Ambry Genetics Corp. Miscellaneous Commercial ServicesCommercial Services Ambry Genetics Corp. provides clinical genetic diagnostics and genetics software solutions. Its services include clinical diagnostics tests, forms, billing, order kits, patient resources about cancer, cardiology, billing information and research and collaboration services. The company was founded by Charles L.M. Dunlop and James Dunlop in 1999 and is headquartered in Aliso Viejo, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
VERACYTE, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Hoag Memorial Hospital Presbyterian, Inc.
Hoag Memorial Hospital Presbyterian, Inc. Hospital/Nursing ManagementHealth Services Hoag Memorial Hospital Presbyterian, Inc. provides healthcare services. It also provides emergency care, orthopedic services, chemical dependency programs, cardiac care, women's health services, and cancer treatment. The company was founded in 1952 and is headquartered in Newport Beach, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Neil M. Barth
University of Toledo Medical Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VERACYTE, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
Hoag Memorial Hospital Presbyterian, Inc.
Hoag Memorial Hospital Presbyterian, Inc. Hospital/Nursing ManagementHealth Services Hoag Memorial Hospital Presbyterian, Inc. provides healthcare services. It also provides emergency care, orthopedic services, chemical dependency programs, cardiac care, women's health services, and cancer treatment. The company was founded in 1952 and is headquartered in Newport Beach, CA. | Health Services |
Ambry Genetics Corp.
Ambry Genetics Corp. Miscellaneous Commercial ServicesCommercial Services Ambry Genetics Corp. provides clinical genetic diagnostics and genetics software solutions. Its services include clinical diagnostics tests, forms, billing, order kits, patient resources about cancer, cardiology, billing information and research and collaboration services. The company was founded by Charles L.M. Dunlop and James Dunlop in 1999 and is headquartered in Aliso Viejo, CA. | Commercial Services |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
Newport Pacific Medical Associates |